LabGenius
About:
LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
Website: http://www.labgeni.us
Twitter/X: labgeni_us
Top Investors: Innovate UK, Lux Capital, Felicis, Octopus Ventures, Atomico
Description:
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics.
Total Funding Amount:
$73.1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2012-09-01
Contact Email:
hi(AT)labgeni.us
Founders:
Harry Rickerby, James Field
Number of Employees:
51-100
Last Funding Date:
2024-05-21
IPO Status:
Private
© 2024 MyAiNote.com